• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病急症:左旋多巴凝胶治疗期间的无动性危象、危及生命的运动障碍和多发性神经病。

Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment.

机构信息

Institute of Neurology, Movement Disorders Center, Department of Oncology and Neuroscience, University G. D'Annunzio Chieti-Pescara, Italy.

出版信息

Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S233-6. doi: 10.1016/S1353-8020(09)70821-1.

DOI:10.1016/S1353-8020(09)70821-1
PMID:20082998
Abstract

This article reviews literature on three emergencies in Parkinson's disease (PD): Akinetic crisis, severe dyskinesias or life-threatening dyskinesias, and polyneuropathy during duodenal L-Dopa gel infusion treatment. Akinetic crisis is also known as Parkinsonian hyperpyrexia, Neuroleptic-like malignant syndrome, Acute akinesia, and Malignant syndrome in parkinsonism. It appears in 0.3% of PD patients/year, and is characterized in the most severe cases by total akinesia with dysphagia, hyperthermia, dysautonomia, increment of muscle enzymes and alterations of mental status, but it may also appear in less severe forms ("forme frusta"). At difference with the continuum of motor hypokinesias observed in PD it is characterized by transient (in cases with favorable outcome) unresponsiveness to rescue drugs. Life-supporting measures are mandatory in patients affected by this emergency. Severe dyskinesia, or life-threatening dyskinesia, is due to increased dopaminergic stimulation (either by the patient or by the prescriber): when it appears the level of dopaminomimetic stimulation should be reduced. Polyneuropathy during duodenal L-Dopa gel infusion is a recently described complication, attributed to the onset of Guillain-Barré syndromes. However, hemapheresis was not effective in some reported cases, and recent evidence suggests that Vitamin B12 deficiency or direct high-dose chronic L-Dopa toxicity might play a role in its origin.

摘要

本文综述了帕金森病(PD)三种急症的文献:运动不能危象、严重运动障碍或危及生命的运动障碍,以及十二指肠 L-Dopa 凝胶输注治疗期间的多发性神经病。运动不能危象又称帕金森高热、神经阻滞剂恶性综合征、急性运动不能、帕金森病恶性综合征。它在 0.3%的 PD 患者/年中出现,在最严重的情况下表现为完全运动不能伴吞咽困难、高热、自主神经功能障碍、肌肉酶升高和精神状态改变,但也可能以较轻的形式出现(“不全危象”)。与 PD 中观察到的运动低下连续体不同,它的特征是对抢救药物的短暂(在预后良好的情况下)无反应。受此急症影响的患者需要采取生命支持措施。严重运动障碍或危及生命的运动障碍是由于多巴胺能刺激增加(无论是由患者还是由处方者引起):当出现这种情况时,应降低多巴胺激动剂的刺激水平。十二指肠 L-Dopa 凝胶输注期间的多发性神经病是一种新描述的并发症,归因于格林-巴利综合征的发作。然而,在一些报告的病例中,血浆置换并不有效,最近的证据表明,维生素 B12 缺乏或直接高剂量慢性 L-Dopa 毒性可能在其发病机制中起作用。

相似文献

1
Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment.帕金森病急症:左旋多巴凝胶治疗期间的无动性危象、危及生命的运动障碍和多发性神经病。
Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S233-6. doi: 10.1016/S1353-8020(09)70821-1.
2
[Development of dyskinesias induced by treatment for Parkinson's disease: potential role of first exposure to L-DOPA (or phenomenon of priming)].帕金森病治疗引起的运动障碍的发展:首次接触左旋多巴的潜在作用(或启动现象)
Rev Neurol (Paris). 2000 Mar;156(3):224-35.
3
[Social and economic cost of L-Dopa-induced dyskinesias in patients with Parkinson's disease].[帕金森病患者左旋多巴诱发异动症的社会和经济成本]
Rev Neurol (Paris). 2001 May;157(5):507-14.
4
Low doses of sarizotan reduce dyskinesias and maintain antiparkinsonian efficacy of L-Dopa in parkinsonian monkeys.低剂量的司立吉林可减少帕金森病猴的异动症,并维持左旋多巴的抗帕金森病疗效。
Parkinsonism Relat Disord. 2009 Jul;15(6):445-52. doi: 10.1016/j.parkreldis.2008.11.001. Epub 2009 Feb 3.
5
Treatment of Parkinson's disease: levodopa as the first choice.帕金森病的治疗:左旋多巴为首选。
J Neurol. 2002 Sep;249 Suppl 2:II19-24. doi: 10.1007/s00415-002-1204-4.
6
[Current preclinical findings on substances against Parkinson's disease].[目前关于抗帕金森病物质的临床前研究结果]
Nervenarzt. 2003 Mar;74 Suppl 1:S2-6. doi: 10.1007/s00115-003-1481-x.
7
ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice.细胞外信号调节激酶(ERK)磷酸化和FosB表达与偏侧帕金森病小鼠左旋多巴诱导的异动症有关。
Biol Psychiatry. 2006 Jan 1;59(1):64-74. doi: 10.1016/j.biopsych.2005.05.044. Epub 2005 Sep 1.
8
[Dyskinesia caused by L-DOPA].[左旋多巴引起的运动障碍]
Rev Neurol (Paris). 2002 Dec;158 Spec no 1:S92-101.
9
Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia.联合5-HT1A和5-HT1B受体激动剂治疗左旋多巴诱导的运动障碍。
Brain. 2008 Dec;131(Pt 12):3380-94. doi: 10.1093/brain/awn235. Epub 2008 Oct 24.
10
Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia.左旋多巴诱导的异动症小鼠模型的药理学验证
Exp Neurol. 2005 Jul;194(1):66-75. doi: 10.1016/j.expneurol.2005.02.002.

引用本文的文献

1
Akinetic crisis and withdrawal syndromes: guideline "Parkinson's disease" of the German Society of Neurology.运动不能危象和戒断综合征:德国神经病学学会“帕金森病”指南
J Neurol. 2024 Oct;271(10):6485-6493. doi: 10.1007/s00415-024-12649-x. Epub 2024 Aug 27.
2
The akinetic crisis in Parkinson´s disease- the upper end of a spectrum of subacute akinetic states.帕金森病的无动性危象——亚急性无动性状态谱的高端。
J Neural Transm (Vienna). 2024 Oct;131(10):1199-1207. doi: 10.1007/s00702-024-02817-8. Epub 2024 Aug 17.
3
Toxin Induced Parkinsonism and Hospitalization Related Adverse Outcome Mitigation for Parkinson's Disease: A Comprehensive Review.
毒素诱发的帕金森病及帕金森病住院相关不良结局的缓解:一项综合综述
J Clin Med. 2023 Jan 30;12(3):1074. doi: 10.3390/jcm12031074.
4
Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism.新型冠状病毒肺炎与帕金森病:急性临床意义、长新冠和新冠后帕金森病。
Int Rev Neurobiol. 2022;165:63-89. doi: 10.1016/bs.irn.2022.04.004. Epub 2022 Aug 8.
5
Neuroleptic malignant-like syndrome associated multiple system atrophy: report on three cases.神经阻滞剂恶性综合征样相关多系统萎缩:三例报告。
BMC Neurol. 2022 Feb 25;22(1):67. doi: 10.1186/s12883-022-02583-8.
6
Gastrointestinal Dysfunction in Parkinson's Disease.帕金森病中的胃肠功能障碍
Drugs. 2022 Feb;82(2):169-197. doi: 10.1007/s40265-021-01664-1. Epub 2022 Jan 25.
7
An overview of pain in Parkinson's disease.帕金森病中的疼痛概述。
Clin Park Relat Disord. 2019 Nov 28;2:1-8. doi: 10.1016/j.prdoa.2019.11.004. eCollection 2020.
8
Emergencies and critical issues in Parkinson's disease.帕金森病的紧急情况与关键问题
Pract Neurol. 2020 Feb;20(1):15-25. doi: 10.1136/practneurol-2018-002075. Epub 2019 Aug 19.
9
Neuroleptic malignant syndrome as part of an akinetic crisis associated with sepsis in a patient with Lewy body disease.在一名路易体病患者中,神经阻滞剂恶性综合征作为与脓毒症相关的运动不能危象的一部分。
BMJ Case Rep. 2019 Feb 28;12(2):e227216. doi: 10.1136/bcr-2018-227216.
10
Malignant Subthalamic Nucleus-Deep Brain Stimulation Withdrawal Syndrome in Parkinson's Disease.帕金森病中恶性丘脑底核-脑深部电刺激撤停综合征
Mov Disord Clin Pract. 2016 Mar 31;3(3):288-291. doi: 10.1002/mdc3.12271. eCollection 2016 May-Jun.